Clinical Trials Browser

Observational × dabrafenib × 90 days × Clear all

NCT04666272 2026-02-19

Effectiveness and Safety of Dabrafenib in Combination With Trametinib as Adjuvant Treatment for Chinese Patients With Stage III BRAF V600 Mutation-positive Melanoma After Complete Resection

Active not recruiting

Melanoma

NCT07419932 2026-02-19

NeoLATC

Thyroid Neoplasms

NCT06262919 2025-12-30

Special Drug Use-results Surveillance of Tafinlar/Mekinist

Recurrence